KSD-201

Kousai Bio Co., Ltd. · Phase 1 active Biologic

At a glance

Generic name	KSD-201
Sponsor	Kousai Bio Co., Ltd.
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study (EARLY_PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

KSD-201 CI brief — competitive landscape report
KSD-201 updates RSS · CI watch RSS
Kousai Bio Co., Ltd. portfolio CI